HK1116807A1 - Vasopressin v1a receptor agonists v1a - Google Patents

Vasopressin v1a receptor agonists v1a

Info

Publication number
HK1116807A1
HK1116807A1 HK08111918.8A HK08111918A HK1116807A1 HK 1116807 A1 HK1116807 A1 HK 1116807A1 HK 08111918 A HK08111918 A HK 08111918A HK 1116807 A1 HK1116807 A1 HK 1116807A1
Authority
HK
Hong Kong
Prior art keywords
vasopressin
receptor agonists
agonists
receptor
Prior art date
Application number
HK08111918.8A
Other languages
English (en)
Chinese (zh)
Inventor
Kazimierz Wisniewski
Robert Felix Galyean
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HK1116807A1 publication Critical patent/HK1116807A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK08111918.8A 2006-02-10 2008-10-30 Vasopressin v1a receptor agonists v1a HK1116807A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77187006P 2006-02-10 2006-02-10
PCT/US2007/003213 WO2007095021A2 (en) 2006-02-10 2007-02-05 Novel compounds

Publications (1)

Publication Number Publication Date
HK1116807A1 true HK1116807A1 (en) 2009-01-02

Family

ID=38371994

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08111918.8A HK1116807A1 (en) 2006-02-10 2008-10-30 Vasopressin v1a receptor agonists v1a

Country Status (14)

Country Link
US (1) US8883965B2 (no)
EP (1) EP1981900B1 (no)
JP (1) JP5185830B2 (no)
KR (1) KR101194586B1 (no)
CN (1) CN101379076B (no)
AU (1) AU2007215406B2 (no)
CA (1) CA2641959C (no)
ES (1) ES2535434T3 (no)
HK (1) HK1116807A1 (no)
IL (1) IL192824A (no)
NO (1) NO20083853L (no)
NZ (1) NZ569836A (no)
RU (1) RU2415149C2 (no)
WO (1) WO2007095021A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
RU2415149C2 (ru) * 2006-02-10 2011-03-27 Ферринг Б.В. Пептидные соединения
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
MX2011002836A (es) 2008-09-17 2011-04-28 Chiasma Inc Composiciones farmaceúticas y métodos de administración relacionados.
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
AU2017345720B2 (en) 2016-10-21 2023-07-27 Chiasma, Inc. Terlipressin compositions and their methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1076984A (en) 1963-04-05 1967-07-26 Sandoz Ltd Improvements in or relating to local anaesthetics containing orn-vasopressin
NL129421C (no) * 1963-08-30 1900-01-01
CS235151B1 (cs) 1982-08-26 1985-05-15 Michal Lebl Způsob dělení Dal isomerů analogů oxytocinu
US4829051A (en) * 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
CS242062B1 (cs) 1984-08-23 1986-04-17 Milan Zaoral Vasopresinová a vasotocinová analoga a způsob jejich přípravy
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
SE469473B (sv) 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider
SE502644C2 (sv) 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
RU2063979C1 (ru) 1992-02-24 1996-07-20 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Пептиды последовательности окситоцина
US5516795A (en) * 1994-09-12 1996-05-14 Abbott Laboratories Heteroatom substituted propanyl derivatives having 5-lipoxygenase inhibitory activity
GB9617021D0 (en) * 1996-08-13 1996-09-25 Salpep Biotechnology Inc Novel peptides for treatment of inflammation and shock
SE9701161D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
IL138214A0 (en) 1998-03-09 2001-10-31 Zealand Pharmaceuticals As Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE0001440D0 (sv) 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
WO2002064740A2 (en) 2001-02-09 2002-08-22 Cognetix, Inc. Cone snail peptides
AU2003220919A1 (en) 2002-03-29 2003-10-13 Wakamoto Pharmaceutical Co., Ltd. Drugs for increasing lacrimal fluid
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
CA2500831A1 (en) 2002-10-03 2004-04-15 Eric Hollander Treatment of autism and similar disorders
CA2557520C (en) * 2003-02-26 2011-09-13 Donald W. Landry A method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
RU2415149C2 (ru) 2006-02-10 2011-03-27 Ферринг Б.В. Пептидные соединения
US8222202B2 (en) * 2006-02-13 2012-07-17 Ferring B.V. Use of peptidic vasopressin receptor agonists
RU2342949C1 (ru) 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists

Also Published As

Publication number Publication date
CA2641959A1 (en) 2007-08-23
WO2007095021A2 (en) 2007-08-23
ES2535434T3 (es) 2015-05-11
WO2007095021A3 (en) 2008-04-24
KR101194586B1 (ko) 2012-10-25
CN101379076B (zh) 2012-11-07
AU2007215406A1 (en) 2007-08-23
JP2009526061A (ja) 2009-07-16
CA2641959C (en) 2016-12-20
RU2008131907A (ru) 2010-03-20
US20090275522A1 (en) 2009-11-05
IL192824A0 (en) 2011-08-01
EP1981900A2 (en) 2008-10-22
JP5185830B2 (ja) 2013-04-17
CN101379076A (zh) 2009-03-04
US8883965B2 (en) 2014-11-11
EP1981900B1 (en) 2015-01-28
KR20080091802A (ko) 2008-10-14
RU2415149C2 (ru) 2011-03-27
EP1981900A4 (en) 2011-01-26
NZ569836A (en) 2010-09-30
AU2007215406B2 (en) 2011-12-08
IL192824A (en) 2015-04-30
NO20083853L (no) 2008-09-30

Similar Documents

Publication Publication Date Title
HRP20151108T1 (en) Nogo receptor antagonists
EP2151236A4 (en) G PROTEIN COUPLED RECEPTOR AGONIST
EP2058304A4 (en) P2X4 RECEPTOR ANTAGONIST
EP2041120A4 (en) MELANOCORTIN RECEPTOR AGONISTS
GB0607196D0 (en) G-protein coupled receptor agonists
EP2049520A4 (en) indole compounds
IL180020A0 (en) Encryption -and decryption-enabled interfaces
GB0700122D0 (en) GPCR agonists
PL1889700T3 (pl) Agregat wielofunkcyjny
EP2221308A4 (en) BENZAZEPINONE COMPOUND
HK1116807A1 (en) Vasopressin v1a receptor agonists v1a
ZA200900843B (en) Indole compounds
HK1121417A1 (en) Dispersing unit
AP2752A (en) Poly-TLR antagonist
ZA200806237B (en) Cannibinoid receptor modulators
GB2437278A8 (en) Fibre dispenser
GB0623399D0 (en) Receptor
GB0608516D0 (en) Receptor
GB0604684D0 (en) Receptor
GB0623853D0 (en) Receptor
AU3984P (en) Sprilecpink Cordyline banksii
GB0612897D0 (en) GPCR agonists
IL176507A0 (en) Dopamine receptor modulation
GB0516439D0 (en) EP2 receptor agonists
GB0625930D0 (en) An improved dispenser

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230205